Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women (ESSAG)
Cervical Cancer
About this trial
This is an interventional screening trial for Cervical Cancer focused on measuring Prevention, Screening
Eligibility Criteria
Inclusion Criteria: women between 31-64 years old living in Flanders eligible for the Flemish actions with regard to population screening without a smear registered in the Belgian Cancer Registry in the last 6 years registered as GMD patient in one of the participating GP practices Exclusion Criteria: hysterectomy pregnancy (past) diagnosis of cervical cancer
Sites / Locations
- Ghent UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
No Intervention
A Self sampling device (SSD) provided by the general practitioner (GP)
B Self sampling device provided by letter
C (control arm) Recommendation letter
A self sampling device will be provided by the GP.
A self sampling device will be provided by letter.
Following the usual care procedure, a random sample of 1125 Flemish women who meet the same inclusion criteria as in arm A and B and are not included in one of the latter arms is drawn by "Centrum voor Kankeropsporing" (CvKO) from Heracles, the database of the Flemish screening program.